We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
256 hedge funds and large institutions have $1.47B invested in Amphastar Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 90 increasing their positions, 93 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
46% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 28
4% more funds holding
Funds holding: 246 → 256 (+10)
5% more call options, than puts
Call options by funds: $1.25M | Put options by funds: $1.19M
0.43% more ownership
Funds ownership: 65.07% → 65.5% (+0.43%)
3% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 93
18% less capital invested
Capital invested by funds: $1.8B → $1.47B (-$332M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
256
Holders Change
+10
Holders Change %
+4.07%
% of All Funds
4.06%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
41
Increased
90
Reduced
93
Closed
28
Calls
$1.25M
Puts
$1.19M
Net Calls
+$60K
Net Calls Change
-$835K
Top Buyers
Top Sellers
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$11M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$8.19M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$5.75M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$4.15M |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
-$3.69M |
